Michael Quinn

NPI: 1225370893
Total Payments
$666.32
2024 Payments
$243.11
Companies
9
Transactions
17
Medicare Patients
2,490
Medicare Billing
$318,745

Payment Breakdown by Category

Food & Beverage$666.32 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $666.32 17 100.0%

Top Paying Companies

Company Total Records Latest Year
Salix Pharmaceuticals, a division of Bausch Health US, LLC $295.97 2 $0 (2024)
Intera Oncology, Inc $128.75 1 $0 (2024)
ABBVIE INC. $87.23 5 $0 (2023)
Celgene Corporation $50.11 3 $0 (2022)
Takeda Pharmaceuticals U.S.A., Inc. $44.28 2 $0 (2022)
Ferring Pharmaceuticals Inc. $16.84 1 $0 (2022)
Gilead Sciences, Inc. $15.91 1 $0 (2023)
NESTLE HEALTHCARE NUTRITION INC. $14.94 1 $0 (2023)
Merck Sharp & Dohme LLC $12.29 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $243.11 2 Intera Oncology, Inc ($128.75)
2023 $248.35 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($181.61)
2022 $174.86 10 ABBVIE INC. ($51.34)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/05/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $114.36 General
Category: Gastroenterology
02/29/2024 Intera Oncology, Inc INTERA (Device) Food and Beverage In-kind items and services $128.75 General
Category: ONCOLOGY
10/30/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $181.61 General
Category: Gastroenterology
08/25/2023 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.54 General
Category: IMMUNOLOGY
08/21/2023 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.91 General
02/28/2023 ABBVIE INC. LINZESS (Drug), VIBERZI Food and Beverage In-kind items and services $17.35 General
Category: GASTROENTEROLOGY
01/27/2023 NESTLE HEALTHCARE NUTRITION INC. ZENPEP (Drug) Food and Beverage In-kind items and services $14.94 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/16/2022 Merck Sharp & Dohme LLC DIFICID (Drug) Food and Beverage In-kind items and services $12.29 General
Category: INFECTIOUS DISEASE
12/09/2022 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.93 General
Category: Neuroscience
11/11/2022 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.08 General
Category: Neuroscience
11/05/2022 ABBVIE INC. CREON (Drug) Food and Beverage In-kind items and services $14.63 General
Category: ENDOCRINOLOGY
10/27/2022 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $14.53 General
Category: ENDOCRINOLOGY
10/14/2022 Takeda Pharmaceuticals U.S.A., Inc. GATTEX (Drug) Food and Beverage In-kind items and services $22.32 General
Category: INTERNAL MEDICINE
09/30/2022 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.96 General
Category: INTERNAL MEDICINE
09/23/2022 Ferring Pharmaceuticals Inc. Food and Beverage In-kind items and services $16.84 General
09/02/2022 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $15.10 General
Category: Neuroscience
07/29/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $22.18 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 16 996 1,154 $226,115 $127,700
2022 13 772 820 $176,329 $98,168
2021 11 722 807 $164,793 $92,877
Total Patients
2,490
Total Services
2,781
Medicare Billing
$318,745
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 243 257 $51,705 $35,435 68.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 157 157 $50,410 $30,873 61.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 153 292 $21,290 $16,643 78.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 200 203 $37,950 $12,299 32.4%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 24 24 $4,451 $4,354 97.8%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 50 50 $13,000 $4,244 32.6%
43274 Insertion of stent into pancreatic or bile duct using a flexible endoscope Facility 2023 11 13 $6,034 $4,203 69.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 21 21 $3,990 $3,804 95.3%
45390 Removal of large bowel tissue using a flexible endoscope Facility 2023 11 11 $4,521 $2,997 66.3%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 31 31 $8,861 $2,656 30.0%
43246 Insertion of stomach tube using a flexible endoscope Facility 2023 16 16 $3,216 $2,514 78.2%
43264 Removal of stone or debris from bile or pancreatic duct using a flexible endoscope Facility 2023 21 21 $8,673 $2,452 28.3%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 16 16 $3,812 $1,883 49.4%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 17 17 $3,662 $1,675 45.7%
43247 Removal of foreign bodies of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 11 11 $3,842 $1,430 37.2%
74328 Review by radiologist of image from tube placement into bile duct using an endoscope Facility 2023 14 14 $700.00 $238.52 34.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 141 143 $44,677 $26,849 60.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 74 76 $15,109 $11,694 77.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 95 95 $16,238 $10,819 66.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Office 2022 18 18 $8,230 $6,359 77.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 53 68 $8,472 $6,163 72.7%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 120 120 $21,342 $5,967 28.0%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 71 99 $7,086 $5,505 77.7%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2022 27 27 $5,779 $4,711 81.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Office 2022 27 27 $10,157 $4,566 45.0%

About Michael Quinn

Michael Quinn is a Internal Medicine healthcare provider based in Christiansburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2013. The National Provider Identifier (NPI) number assigned to this provider is 1225370893.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Quinn has received a total of $666.32 in payments from pharmaceutical and medical device companies, with $243.11 received in 2024. These payments were reported across 17 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($666.32).

As a Medicare-enrolled provider, Quinn has provided services to 2,490 Medicare beneficiaries, totaling 2,781 services with total Medicare billing of $318,745. Data is available for 3 years (2021–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Student in an Organized Health Care Education/Training Program, Gastroenterology
  • Location Christiansburg, VA
  • Active Since 03/21/2013
  • Last Updated 12/21/2023
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1225370893

Products in Payments

  • XIFAXAN (Drug) $295.97
  • INTERA (Device) $128.75
  • ZEPOSIA (Drug) $50.11
  • CREON (Drug) $29.16
  • GATTEX (Drug) $22.32
  • SKYRIZI (Biological) $22.18
  • ENTYVIO (Biological) $21.96
  • RINVOQ (Biological) $18.54
  • LINZESS (Drug) $17.35
  • ZENPEP (Drug) $14.94
  • DIFICID (Drug) $12.29

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Christiansburg